Conversely, later-onset gliomas were associated with the IDHwt subtype paired with EGFR or MDM4 amplification, as well as with CDKN2A, CDKN2B, or PTEN deletion (FDR <0.015). Here, CDKN2A is linked to central nervous system cancer.